B

BSIM Therapeutics

4 employees

Small Molecule Therapeutics against Transthyretin-Mediated Amyloidoses

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
hATTR-PN
Transthyretin
Drug Discovery
Rare Diseases
Amyloidosis
hATTR-CM
Lead Optimisation
Therapeutics
Orphan Drugs
Medicinal Chemistry
Drug Development
wtATTR
Lead Discovery

Date founded

2011

Funding rounds raised

Total raised

$585K

from 1 investors over 1 rounds

B

BSIM Therapeutics raised $585K on February 13, 2017

Investors: Portugal Ventures

FAQ